IMNM logo

Immunome, Inc. (IMNM) Operating profit

annual operating profit:

-$153.46M-$124.73M(-434.17%)
December 31, 2024

Summary

  • As of today (September 15, 2025), IMNM annual operating income is -$153.46 million, with the most recent change of -$124.73 million (-434.17%) on December 31, 2024.
  • During the last 3 years, IMNM annual operating profit has fallen by -$128.25 million (-508.86%).
  • IMNM annual operating profit is now -1881.87% below its all-time high of -$7.74 million, reached on December 31, 2018.

Performance

IMNM Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMincome statement metrics

quarterly operating profit:

-$46.48M-$1.84M(-4.13%)
June 1, 2025

Summary

  • As of today (September 15, 2025), IMNM quarterly operating income is -$46.48 million, with the most recent change of -$1.84 million (-4.13%) on June 1, 2025.
  • Over the past year, IMNM quarterly operating profit has dropped by -$12.78 million (-37.93%).
  • IMNM quarterly operating profit is now -1650.58% below its all-time high of -$2.65 million, reached on March 31, 2020.

Performance

IMNM quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMincome statement metrics

TTM operating profit:

-$190.53M-$12.78M(-7.19%)
June 1, 2025

Summary

  • As of today (September 15, 2025), IMNM TTM operating income is -$190.53 million, with the most recent change of -$12.78 million (-7.19%) on June 1, 2025.
  • Over the past year, IMNM TTM operating profit has dropped by -$118.00 million (-162.70%).
  • IMNM TTM operating profit is now -6904.71% below its all-time high of -$2.72 million, reached on September 30, 2019.

Performance

IMNM TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

IMNM Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-434.2%-37.9%-162.7%
3 y3 years-508.9%-420.7%-427.1%
5 y5 years-1383.0%-1611.9%-1635.5%

IMNM Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-508.9%at low-939.5%+16.4%-740.7%at low
5 y5-year-1383.0%at low-1611.9%+16.4%-1635.5%at low
alltimeall time-1881.9%at low-1650.6%+16.4%-6904.7%at low

IMNM Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$46.48M(+4.1%)
-$190.53M(+7.2%)
Mar 2025
-
-$44.64M(-19.7%)
-$177.75M(+15.8%)
Dec 2024
-$153.46M(+434.2%)
-$55.60M(+26.9%)
-$153.46M(+37.4%)
Sep 2024
-
-$43.82M(+30.0%)
-$111.71M(+54.0%)
Jun 2024
-
-$33.70M(+65.6%)
-$72.53M(+62.6%)
Mar 2024
-
-$20.34M(+46.9%)
-$44.60M(+55.3%)
Dec 2023
-$28.73M(-22.1%)
-$13.85M(+199.0%)
-$28.73M(+26.8%)
Sep 2023
-
-$4.63M(-19.7%)
-$22.66M(-14.7%)
Jun 2023
-
-$5.77M(+29.1%)
-$26.57M(-10.6%)
Mar 2023
-
-$4.47M(-42.6%)
-$29.72M(-19.5%)
Dec 2022
-$36.90M
-$7.79M(-8.8%)
-$36.90M(-0.2%)
Sep 2022
-
-$8.53M(-4.4%)
-$36.96M(+2.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$8.93M(-23.4%)
-$36.15M(+9.7%)
Mar 2022
-
-$11.65M(+48.6%)
-$32.96M(+30.8%)
Dec 2021
-$25.20M(+105.6%)
-$7.84M(+1.6%)
-$25.20M(+17.6%)
Sep 2021
-
-$7.72M(+34.5%)
-$21.43M(+29.7%)
Jun 2021
-
-$5.74M(+47.3%)
-$16.53M(+22.4%)
Mar 2021
-
-$3.90M(-4.3%)
-$13.50M(+10.1%)
Dec 2020
-$12.26M(+18.5%)
-$4.07M(+44.5%)
-$12.26M(+10.7%)
Sep 2020
-
-$2.82M(+3.8%)
-$11.08M(+0.9%)
Jun 2020
-
-$2.71M(+2.3%)
-$10.98M(+32.9%)
Mar 2020
-
-$2.65M(-8.1%)
-$8.26M(+47.3%)
Dec 2019
-$10.35M(+33.6%)
-$2.89M(+6.2%)
-$5.61M(+106.2%)
Sep 2019
-
-$2.72M
-$2.72M
Dec 2018
-$7.74M
-
-

FAQ

  • What is Immunome, Inc. annual operating income?
  • What is the all time high annual operating profit for Immunome, Inc.?
  • What is Immunome, Inc. annual operating profit year-on-year change?
  • What is Immunome, Inc. quarterly operating income?
  • What is the all time high quarterly operating profit for Immunome, Inc.?
  • What is Immunome, Inc. quarterly operating profit year-on-year change?
  • What is Immunome, Inc. TTM operating income?
  • What is the all time high TTM operating profit for Immunome, Inc.?
  • What is Immunome, Inc. TTM operating profit year-on-year change?

What is Immunome, Inc. annual operating income?

The current annual operating profit of IMNM is -$153.46M

What is the all time high annual operating profit for Immunome, Inc.?

Immunome, Inc. all-time high annual operating income is -$7.74M

What is Immunome, Inc. annual operating profit year-on-year change?

Over the past year, IMNM annual operating income has changed by -$124.73M (-434.17%)

What is Immunome, Inc. quarterly operating income?

The current quarterly operating profit of IMNM is -$46.48M

What is the all time high quarterly operating profit for Immunome, Inc.?

Immunome, Inc. all-time high quarterly operating income is -$2.65M

What is Immunome, Inc. quarterly operating profit year-on-year change?

Over the past year, IMNM quarterly operating income has changed by -$12.78M (-37.93%)

What is Immunome, Inc. TTM operating income?

The current TTM operating profit of IMNM is -$190.53M

What is the all time high TTM operating profit for Immunome, Inc.?

Immunome, Inc. all-time high TTM operating income is -$2.72M

What is Immunome, Inc. TTM operating profit year-on-year change?

Over the past year, IMNM TTM operating income has changed by -$118.00M (-162.70%)
On this page